Keyword: Bristol-Myers Squibb (BMS)

Chemistry & Life Sciences

Trend Barometer of Specialty Chemicals Industry

16.07.2019 - The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. During...

News

Catalent Buys Facilities in US and Italy

08.07.2019 - Catalent Biologics, through its Paragon Gene Therapy business, has agreed to assume the leases to two Novavax facilities in Maryland, USA. The move, said Novavax, will reduce its...

News

Catalent Buying BMS Site in Italy

24.06.2019 - Continuing a buying spree that has added adding biologics and gene therapy capabilities to its manufacturing repertoire, California-based US drug developer Catalent is buying a...

News

BMS Shareholders Greenlight Celgene Deal

17.04.2019 - Shareholders of Bristol Myers Squibb (BMS) have approved the company’s $74 billion acquisition of Celgene. At the special meeting on Apr. 12, altogether 75% of the shareholders...

Strategy & Management

The Need for Innovation in Pharmaceutical Manufacturing

08.04.2019 - The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...

News

Starboard Backs Away from BMS-Celgene Bust-up

02.04.2019 - Activist investor Starboard Value has backed away from plans to torpedo the proposed $74 billion merger of Bristol-Myers Squibb with Celgene after independent proxy advisory firms...

News

BMS Shareholders Fight Celgene Takeover

01.03.2019 - Activist investor Starboard Value, which very recently bought a 1 million share in Bristol-Myers Squibb (BMS) and nominated five directors to the board, has now made public its...

News

Activist Starboard Meets BMS Management

22.02.2019 - Activist shareholder Starboard Value has acquired an interest of 1 million share of Bristol-Myers Squibb (BMS) and has held meetings with management, the US drugmaker said. BMS...